BioCentury
ARTICLE | Company News

Neoprobe management update

April 4, 2011 7:00 AM UTC

Neoprobe Corp. (NYSE:NEOP), Dublin, Ohio Business: Diagnostic Transitioning: Mark Pykett to president, CEO and a director, effective April 15, from EVP and chief development officer; he succeeds David...